InvestorsHub Logo
Followers 611
Posts 26792
Boards Moderated 1
Alias Born 08/12/2010

Re: buccaneer1961 post# 9808

Sunday, 05/08/2011 9:16:59 AM

Sunday, May 08, 2011 9:16:59 AM

Post# of 30951
This Is HUGE!!!


First things first:
HAPPY MOTHERS DAY!!!


****
With an aging population here in the U.S. to have a kit that can help detect cardiovascular issues resulting is the potential for heart attack and stroke is Huge... Prevention and immediate treatment are keys to success. These kits will be vital in that effort. Ultimate goal to save lives, maintain quality of life, and reduce costs in the health industry. Win win situation in the attempt to provide better health care at YES reduced costs....

I would buy a kit out of my on pocket hands down!

Provide this in the two largest potential markets U.S. and China. This group is on track and they are already profitable.

glta....
****

Diagnostic Kits for the Detection of Cardiovascular Diseases


Cardiovascular disease is the single largest killer in the United States. With nearly one million deaths caused by cardiovascular disease each year, stroke and coronary heart disease (CHD) account for more than seventy percent of these fatalities. Cardiovascular disease is the leading cause of death and disability with approximately 500,000 fatal heart attacks and 700,000 strokes per year in the United States alone. More than 15 million Americans have a history of coronary heart disease. The American Heart Association expects direct and indirect costs of coronary heart disease to total nearly $200 billion

Abgenom ,inc has developed two diagnostic kits or rapid test devices for cardiovascular diseases, and now they are being prepared to apply clinical trial both in China and US. The first product in the products pipeline is a rapid test device for early diagnosis of acute myocardial infarction (AMI). (Another product is a test kits for diagnosis of hypertriglyceridemia).